about
[Effect of semax on the temporary dynamics of brain-derived neurotrophic factor and nerve growth factor gene expression in the rat hippocampus and frontal cortex]Effective quantitative real-time polymerase chain reaction analysis of the parkin gene (PARK2) exon 1-12 dosage.Selank Administration Affects the Expression of Some Genes Involved in GABAergic NeurotransmissionA polymorphism within the connective tissue growth factor (CTGF) gene has no effect on non-invasive markers of beta-cell area and risk of type 2 diabetesGenetic Analysis of BDNF, GNB3, MTHFR, ACE and APOE Variants in Major and Recurrent Depressive Disorders in Russia.Peptide Selank Enhances the Effect of Diazepam in Reducing Anxiety in Unpredictable Chronic Mild Stress Conditions in Rats.Molecular mechanisms of pathogenesis of Parkinson's disease.MicroRNAs: possible role in pathogenesis of Parkinson's disease.Differences in relative levels of 88 microRNAs in various regions of the normal adult human brain.GABA, Selank, and Olanzapine Affect the Expression of Genes Involved in GABAergic Neurotransmission in IMR-32 Cells.Involvement of endocytosis and alternative splicing in the formation of the pathological process in the early stages of Parkinson's disease.Second mutation in PARK2 is absent in patients with sporadic Parkinson's disease and heterozygous exonic deletions/duplications in parkin gene.Transcriptome Profile Changes in Mice with MPTP-Induced Early Stages of Parkinson's Disease.GSTM1 copy number variation in the context of single nucleotide polymorphisms in the human GSTM cluster.Potential Biomarkers of the Earliest Clinical Stages of Parkinson's Disease.ITPR1 gene p.Val1553Met mutation in Russian family with mild Spinocerebellar ataxia.Transcriptomic response of rat hippocampus and spleen cells to single and chronic administration of the peptide selank.[Polymorphism of glutathione S-transferases M1 and T1 in several populations of Russia][Role of missense mutation (M235T) in the angiotensinogen gene in development of cerebral ischemia][Association of homozygosity for short allele (S) of heavy neurofilament subunit gene with motor neuron disease and oxidative stress development].[A simple and rapid method for determining a 32-bp deletion in the gene for the chemokine receptor CCR5].[Peculiarities of sporadic motor neuron disease associated with D90A and G12R mutations in Russian population].[Detoxication gene polymorphism and susceptibility to sporadic motor neuron disease in Russian population].[Associations between chronotype, road accidents and polymorphisms in genes linked with biological clock and dopaminergic system].Analysis of heavy neurofilament subunit gene polymorphism in Russian patients with sporadic motor neuron disease (MND).Peptides semax and selank affect the behavior of rats with 6-OHDA induced PD-like parkinsonism.Comparison of the temporary dynamics of NGF and BDNF gene expression in rat hippocampus, frontal cortex, and retina under Semax action.Expression analysis of genes of ubiquitin-proteasome protein degradation system in MPTP-induced mice models of early stages of Parkinson's disease.Clinical and molecular analysis of a large family with three distinct phenotypes of progressive muscular dystrophy.[Transcranial sonography in Parkinson's disease].[Molecular genetic analysis of hereditary neurodegenerative diseases][Possible involvement of neuronal nicotinic acetylcholine receptors in compensatory brain mechanisms at early stages of Parkinson's disease].[Transcriptome alteration in hippocampus under the treatment of tuftsin analog Selank].[Genetic risk factors for recurrence-free urolithiasis in the russian population].[Expression of GSK3B gene in peripheral blood in patient with Parkinson's disease].Expression analysis of suppression of tumorigenicity 13 gene in patients with Parkinson's disease.The temporary dynamics of inflammation-related genes expression under tuftsin analog Selank action.[A PARK8 form of Parkinson's disease: a mutational analysis of the LRRK2 gene in Russian population].[A simple and rapid method for detection of the 106Gln mutation in Wilson-Konovalov disease]Spinocerebellar ataxia type 1 in Russia
P50
Q28570348-9D5C821D-2298-4CA2-BB4C-B9FF2036F504Q33275606-DC84AE3E-814D-47FD-A5ED-56487C2A650DQ36590974-AC6945EC-D7F4-434F-9F08-D6E38590F9B7Q37306046-4833A011-7B0B-4EA2-A604-2B797DE9B862Q37513479-8411F04A-B61F-4B47-BE5B-78FA9EB9A7EFQ37661555-B43D9D55-52A5-4FA5-AC1B-4BF8CA65828EQ37749063-B58D331D-984F-45E8-B486-377E91FE654EQ38031899-4C5B28BC-FDFE-4840-AC26-491ED75E5293Q38775357-8AB0C181-EA6E-436E-9B88-51DA8E4292D1Q38908174-BAD60A1A-F3BE-4550-9C22-F412E0AF004FQ38909797-C2548852-D1C6-4F83-8BCC-A6B6B66F8166Q39230378-6FEE124B-0B3A-4EF4-B36B-4B6B627559CFQ39273083-144F9247-DBF9-4A5F-9EA3-054311B82227Q40377503-B579B735-2430-42C2-8E84-786D56088AFBQ41385214-DB70CF21-C93C-4EAE-9657-7E361619EC6CQ42032072-8E5D5D70-7CB6-48CB-B408-4BBDE294AA6BQ43104964-D8B6B2E8-7AEC-4CF7-AC73-B36C92FF698CQ43920405-F3EB611D-806F-4162-A82A-78FF35FF10A2Q44375227-5946F2D0-D819-4E18-9001-7C459D352DC4Q44389812-CCFB4B69-F752-452D-A05C-4C3B86249BEFQ44683814-C586BC2D-59BD-43DA-804E-C74544057F63Q44697679-C0622A84-C278-4DD3-AB75-B605C1E44556Q46928914-DC12AA3C-068D-4E7B-B2BC-72255ED59983Q47094648-7AC5A7FE-D2C0-4C09-80E4-C170AA8AAA5DQ48094999-AE174333-4CED-475C-BE16-DB4620DC48C2Q48198229-B3140769-895E-4C17-B5C4-A64A7B65A4ADQ48491651-38F86ACC-4359-4F45-93ED-5A087C90B961Q48678369-06D9694B-8FE4-4F5C-A90B-62464BED578AQ48840222-1C816F42-8A3E-4D85-855E-F1D4C1CEED8CQ50265541-36EA20C5-00FA-482C-A347-E64BAE931A42Q50282986-09DBDA0D-AB78-4D41-973D-0D771FCF3512Q50430880-222AE3B9-1C0E-4290-8392-375663C6A47DQ50694436-63515C28-2E84-40B5-8F24-A8FB7BD7D473Q50867674-ABB9BBE2-ED21-4356-91DD-30618EFD8A7AQ54357411-04255982-9A5A-4694-B104-3BE2783DCA0FQ54439314-57C31857-4369-4766-90A4-92076173231AQ54511516-18972E62-771B-4BFA-BD97-EF1E19DDC810Q54539572-AB6E99B4-2BDE-420D-BCEB-B1A385E24416Q54790725-D89DB36E-42FA-4C87-9EF1-BD997F5FB501Q58027536-E8CC6AAA-83C8-4AF4-891F-6C5E39714A08
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Petr Slominsky
@ast
Petr Slominsky
@en
Petr Slominsky
@es
Petr Slominsky
@nl
Petr Slominsky
@sl
Pjotr Andrejewitsch Slominski
@de
Пётр Андреевич Сломинский
@ru
type
label
Petr Slominsky
@ast
Petr Slominsky
@en
Petr Slominsky
@es
Petr Slominsky
@nl
Petr Slominsky
@sl
Pjotr Andrejewitsch Slominski
@de
Пётр Андреевич Сломинский
@ru
altLabel
Petr A Slominsky
@en
Pjotr Slominski
@de
Pyotr Andreyevich Slominsky
@en
Pyotr Slominsky
@en
prefLabel
Petr Slominsky
@ast
Petr Slominsky
@en
Petr Slominsky
@es
Petr Slominsky
@nl
Petr Slominsky
@sl
Pjotr Andrejewitsch Slominski
@de
Пётр Андреевич Сломинский
@ru
P1053
B-4640-2016
P106
P21
P31
P4012
P496
0000-0003-3530-0655